Abstract
Purpose
The purpose of this study was to investigate gender-associated differences in quality of life in colorectal cancer patients and compare such differences to the general population.
Methods
Colorectal cancer patients attending three oncological centres in Austria were consecutively recruited and assessed with the EORTC QLQ-C30. For the purpose of comparison, a gender- and age-matched healthy control group was drawn from a representative sample of the Austrian general population.
Results
About 206 patients (47.1% women; mean age 64.8 years) with colorectal cancer were included and compared with 206 persons from the general population. A two-way analysis of variance showed significant main effects (gender and colorectal cancer vs. healthy) for most EORTC QLQ-C30 scales, but a significant interaction effect was only found for diarrhea. This means that gender-associated differences specific for colorectal cancer patients were only found for diarrhea.
Conclusion
The vast majority of studies on gender-associated differences in quality of life compare male and female oncological patients and neglect the issue of the disease-specificity of such differences. Our study revealed that women and men suffering from colorectal cancer scored differently across many aspects of quality of life, but with the exception of diarrhea, these differences were also found in the general population, i.e. they indicated no gender-specific reaction to disease.
Similar content being viewed by others
Abbreviations
- 5-FU:
-
5-Fluoruracil
- ANOVA:
-
Analysis of variance
- CHES:
-
Computer-based health evaluation system
- CRC:
-
Colorectal cancer
- EORTC:
-
European Organisation for Research and Treatment of Cancer
- GP:
-
General population
- OR:
-
Odds ratio
- QLQ-C30:
-
Quality of life questionnaire-core 30
- QOL:
-
Quality of life
- SD:
-
Standard deviation
- SE:
-
Standard error
- SPSS:
-
Statistical package for the social sciences
- UICC:
-
Union internationale contre le cancer
References
Bethesda, M. (2008). SEER Cancer statistics review 1975–2005. In L. Ries, et al. (Eds.), National Cancer Institute. Retrieved from http://seer.cancer.gov/csr/1975_2005/.
Oberaigner, W., Mühlböck, H., & Harrasser, L. (2004). Kolorektale Karzinome in Tirol. Innsbruck: Institut für Klinische Epidemiologie.
Wichmann, M. W., Muller, C., Hornung, H. M., Lau-Werner, U., & Schildberg, F. W. (2001). Gender differences in long-term survival of patients with colorectal cancer. British Journal of Surgery, 88(8), 1092–1098. doi:10.1046/j.0007-1323.2001.01819.x.
McArdle, C. S., McMillan, D. C., & Hole, D. J. (2003). Male gender adversely affects survival following surgery for colorectal cancer. British Journal of Surgery, 90(6), 711–715. doi:10.1002/bjs.4098.
Wong, N. D., Pio, J., Valencia, R., & Thakal, G. (2001). Distribution of C-reactive protein and its relation to risk factors and coronary heart disease risk estimation in the National Health and Nutrition Examination Survey (NHANES) III. Preventive Cardiology, 4, 109–114. doi:10.1111/j.1520-037X.2001.00570.x.
Winawer, S. J., Fletcher, R. H., Miller, L., Godlee, F., Stolar, M. H., Mulrow, C. D., et al. (1997). Colorectal cancer screening: Clinical guidelines and rationale. Gastroenterology, 112(2), 594–642.
Denberg, T. D., Melhado, T. V., Coombes, J. M., Beaty, B. L., Berman, K., Byers, T. E., et al. (2005). Predictors of nonadherence to screening colonoscopy. Journal of General Internal Medicine, 20(11), 989–995. doi:10.1111/j.1525-1497.2005.00164.x.
Montano, D. E., Selby, J. V., Somkin, C. P., Bhat, A., & Nadel, M. (2004). Acceptance of flexible sigmoidoscopy screening for colorectal cancer. Cancer Detection and Prevention, 28(1), 43–51. doi:10.1016/j.cdp.2003.11.005.
Blom, J., Yin, L., Liden, A., Dolk, A., Jeppsson, B., Paahlman, L., et al. (2008). Toward understanding nonparticipation in sigmoidoscopy screening for colorectal cancer. International Journal of Cancer, 122(7), 1618–1623. doi:10.1002/ijc.23208.
Schmidt, C. E., Bestmann, B., Kuchler, T., Longo, W. E., Rohde, V., & Kremer, B. (2005). Gender differences in quality of life of patients with rectal cancer. A five-year prospective study. World Journal of Surgery, 29(12), 1630–1641. doi:10.1007/s00268-005-0067-0.
Schmidt, C. E., Bestmann, B., Kuchler, T., & Kremer, B. (2005). Factors influencing sexual function in patients with rectal cancer. International Journal of Impotence Research, 17(3), 231–238. doi:10.1038/sj.ijir.3901276.
Arndt, V., Merx, H., Stegmaier, C., Ziegler, H., & Brenner, H. (2004). Quality of life in patients with colorectal cancer 1 year after diagnosis compared with the general population: A population-based study. Journal of Clinical Oncology, 22(23), 4829–4836. doi:10.1200/JCO.2004.02.018.
Heinonen, H., Volin, L., Uutela, A., Zevon, M., Barrick, C., & Ruutu, T. (2001). Gender-associated differences in the quality of life after allogeneic BMT. Bone Marrow Transplantation, 28(5), 503–509. doi:10.1038/sj.bmt.1703158.
Mystakidou, K., Tsilika, E., Parpa, E., Katsouda, E., Galanos, A., & Vlahos, L. (2005). Assessment of anxiety and depression in advanced cancer patients and their relationship with quality of life. Quality of Life Research, 14(8), 1825–1833. doi:10.1007/s11136-005-4324-3.
Jordhoy, M., Fayers, P., Loge, J., Saltnes, T., Ahlner-Elmqvist, M., & Kaasa, S. (2001). Quality of life in advanced cancer patients: The impact of sociodemographic and medical characteristics. British Journal of Cancer, 85(10), 1478–1485. doi:10.1054/bjoc.2001.2116.
Holzner, B., Kemmler, G., Kopp, M., Nguyen-Van-Tam, D., Sperner-Unterweger, B., & Greil, R. (2004). Quality of life of patients with chronic lymphocytic leukemia: Results of a longitudinal investigation over 1 yr. European Journal of Haematology, 72(6), 381–389. doi:10.1111/j.1600-0609.2004.00233.x.
Holzner, B., Kemmler, G., Cella, D., De Paoli, C., Meraner, V., Kopp, M., et al. (2004). Normative data for functional assessment of cancer therapy—general scale and its use for the interpretation of quality of life scores in cancer survivors. Acta Oncologica (Stockholm, Sweden), 43(2), 153–160. doi:10.1080/02841860310023453.
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365–376. doi:10.1093/jnci/85.5.365.
Schwarz, R., & Hinz, A. (2001). Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. European Journal of Cancer, 37(11), 1345–1351. doi:10.1016/S0959-8049(00)00447-0.
Holzner, B., Zabernigg, A., Kemmler, G., Baier, S., Kopp, M., & Sperner Unterweger, B. (2004). Computerized assessment of quality of life in patients undergoing chemotherapy. Quality of Life Research, 13(9), 1523.
Osoba, D., Rodrigues, G., Myles, J., Zee, B., & Pater, J. (1998). Interpreting the significance of changes in health-related quality-of-life scores. Journal of Clinical Oncology, 16(1), 139–144.
Fayers, P., & Machin, D. (2000). Quality of life: Assessment, analysis and interpretation. Chichester: Wiley.
Nolen-Hoeksema, S., Larson, J., & Grayson, C. (1999). Explaining the gender difference in depressive symptoms. Journal of Personality and Social Psychology, 77(6), 1061–1072. doi:10.1037/0022-3514.77.5.1061.
Miaskowski, C. (2004). Gender differences in pain, fatigue, and depression in patients with cancer. Journal of the National Cancer Institute. Monographs, 32, 139–143.
Sloan, J. A., Goldberg, R. M., Sargent, D. J., Vargas-Chanes, D., Nair, S., Cha, S. S., et al. (2002). Women experience greater toxicity with fluorouracil-based chemotherapy for colorectal cancer. Journal of Clinical Oncology, 20(6), 1491–1498. doi:10.1200/JCO.20.6.1491.
Chansky, K., Benedetti, J., & Macdonald, J. S. (2005). Differences in toxicity between men and women treated with 5-fluorouracil therapy for colorectal carcinoma. Cancer, 103(6), 1165–1171. doi:10.1002/cncr.20878.
Hammerlid, E., & Taft, C. (2001). Health-related quality of life in long-term head and neck cancer survivors: A comparison with general population norms. British Journal of Cancer, 84(2), 149–156. doi:10.1054/bjoc.2000.1576.
Wilson, T., & Alexander, D. (2008). Clinical and non-clinical factors influencing postoperative health-related quality of life in patients with colorectal cancer. British Journal of Surgery, 95(11), 1408–1415. doi:10.1002/bjs.6376.
Tsunoda, A., Nakao, K., Hiratsuka, K., Tsunoda, Y., & Kusano, M. (2007). Prospective analysis of quality of life in the first year after colorectal cancer surgery. Acta Oncologica (Stockholm, Sweden), 46(1), 77–82. doi:10.1080/02841860600847053.
Rapkin, B., & Schwartz, C. (2004). Toward a theoretical model of quality-of-life appraisal: Implications of findings from studies of response shift. Health and Quality of Life Outcomes, 2, 14. doi:10.1186/1477-7525-2-14.
Hjermstad, M. J., Fayers, P. M., Bjordal, K., & Kaasa, S. (1998). Health-related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire: The QLQ = C30 (+3). Journal of Clinical Oncology, 16(3), 1188–1196.
Klee, M., Groenvold, M., & Machin, D. (1997). Quality of life of Danish women: Population-based norms of the EORTC QLQ-C30. Quality of Life Research, 6(1), 27–34. doi:10.1023/A:1026461310761.
Velikova, G., Wright, E. P., Smith, A. B., Cull, A., Gould, A., Forman, D., et al. (1999). Automated collection of quality-of-life data: A comparison of paper and computer touch-screen questionnaires. Journal of Clinical Oncology, 17(3), 998–1007.
Taenzer, P., Bultz, B. D., Carlson, L. E., Speca, M., DeGagne, T., Olson, K., et al. (2000). Impact of computerized quality of life screening on physician behaviour and patient satisfaction in lung cancer outpatients. Psycho-Oncology, 9(3), 203–213. doi:10.1002/1099-1611(200005/06)9:3≤203::AID-PON453≥3.0.CO;2-Y.
Greenspan, J. D., Craft, R. M., LeResche, L., Arendt-Nielsen, L., Berkley, K. J., Fillingim, R. B., et al. (2007). Studying sex and gender differences in pain and analgesia: A consensus report. Pain, 132(Suppl 1), S26–S45. doi:10.1016/j.pain.2007.10.014.
Pietrobon, R., Taylor, M., Guller, U., Higgins, L., Jacobs, D., & Carey, T. (2004). Predicting gender differences as latent variables: Summed scores, and individual item responses: A methods case study. Health and Quality of Life Outcomes, 2, 59. doi:10.1186/1477-7525-2-59.
Teresi, J., & Fleishman, J. (2007). Differential item functioning and health assessment. Quality of Life Research, 16(Suppl 1), 33–42. doi:10.1007/s11136-007-9184-6.
Acknowledgments
We would like to thank Sandra Ehrenstrasser for her contribution to data collection, Jakob Pinggera and Stefan Zugal for help with software programming and Wolfgang Fleischhacker for thoughtful comments. Furthermore, we thank the “Arbeitskreis fuer Vorsorgemedizin—Tirol” for administrative assistance in the collection of data from the general population. The “Jubilaeumsfond” of the Austrian National Bank as well as the “Qualitaetsfoerderprogramm” of the state of Tyrol funded parts of the project financially.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Giesinger, J., Kemmler, G., Mueller, V. et al. Are gender-associated differences in quality of life in colorectal cancer patients disease-specific?. Qual Life Res 18, 547–555 (2009). https://doi.org/10.1007/s11136-009-9468-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-009-9468-0